Randomized control study to investigate the effect of adjuvant transcatheter arterial infusion on prevention of early recurrence in patients after radical hepatectomy of hepatocellular carcinoma

Randomized control study to investigate the effect of adjuvant transcatheter arterial infusion on prevention of early recurrence in patients after radical hepatectomy of hepatocellular carcinoma - Randomized control study to investigate the effect of adjuvant transcatheter arterial infusion on prevention of early recurrence in patients after radical hepatectomy of hepatocellular carcinoma

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011900

Enrollment

100

Registered

2013-09-27

Start date

2011-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma (HCC)

Interventions

Transcatheter arterial infusion of CDDP(50mg/m2) in 3 and 6 month after hepatectomy. Best supprtive care

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Patients aged >= 20 years to < 80 years at informed consent and notified disease (2) Child A or B (3) Patients with an ECOG performance status(PS) of 0 or 1 (4) Written Informed consent must be obtained

Exclusion criteria

Exclusion criteria: (1) Child C (2) Patients under dialysis therapy (3) Any patients judged by the investigators to be unfit to participate in the study

Design outcomes

Primary

Measure	Time frame
Disease-free survival	—

Secondary

Measure	Time frame
Within 2 years recurrence overall recurrence overall survival	—

Countries

Japan

Contacts

Public ContactFumitoshi Hirokawa

Osaka Medical College Department of General and Gastroenterological Surgery

sur122@poh.osaka-med.ac.jp072-683-1221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026